Conference Call and Webcast at 8:30AM Eastern Time
NEW
YORK, May 2, 2024 /PRNewswire/ -- Lucid
Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or
the "Company") a commercial-stage, cancer prevention medical
diagnostics company and majority-owned subsidiary of PAVmed Inc.
(Nasdaq: PAVM, PAVMZ), today announced that it will host a business
update conference call and webcast on Monday, May 13, 2024, at 8:30 AM ET. During the call, Lishan Aklog, M.D., Lucid's Chairman and Chief
Executive Officer, will provide a business update, including an
overview of the Company's operations and continued growth strategy.
In addition, Dennis McGrath,
Lucid's Chief Financial Officer, will discuss the Company's first
quarter 2024 financial results.
The webcast will be available at the investor
relations section of the Company's website at luciddx.com.
Alternatively, to access the conference call by telephone,
U.S.-based callers should dial 1-800-836-8184 and international
listeners should dial 1-646-357-8785. All listeners should provide
the operator with the conference call name "Lucid Diagnostics
Business Update" to join.
Following the conclusion of the conference call, a replay will
be available for 30 days on the investor relations section of the
Company's website at luciddx.com.
About Lucid Diagnostics
Lucid Diagnostics Inc. is a
commercial-stage medical diagnostics company focused on cancer
prevention, and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is
focused on the millions of patients with gastroesophageal reflux
disease (GERD), also known as chronic heartburn, who are at risk of
developing esophageal precancer and cancer. Lucid's
EsoGuard® Esophageal DNA Test, performed on samples
collected in a brief, noninvasive office procedure with its
EsoCheck Esophageal Cell Collection Device, is the first and only
commercially available diagnostic test capable of serving as a
widespread screening tool for at-risk patients to mitigate the
risks of cancer and cancer deaths through early detection of
esophageal precancer.
For more information, please visit www.luciddx.com and for more
information about its parent company PAVmed, please visit
www.pavmed.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lucid-diagnostics-to-hold-a-business-update-conference-call-and-webcast-on-may-13-2024-302134279.html
SOURCE Lucid Diagnostics